Filter
594
Text search:
variant
Featured
Recommendations
67
New Publications
90
Language
Document type
No document type
213
Guidelines
135
Studies & Reports
129
Fact sheets
35
Manuals
25
Strategic & Response Plan
24
Situation Updates
16
Videos
6
Resource Platforms
5
Training Material
4
Brochures
1
Infographics
1
Countries / Regions
Global
27
India
26
Senegal
23
Brazil
21
Latin America and the Carribbean
15
South Africa
13
Burkina Faso
12
Congo, Democratic Republic of
12
Central African Republic
11
Western and Central Europe
11
Africa
11
Nigeria
8
Rwanda
8
Benin
8
West and Central Africa
8
Germany
7
Ukraine
7
Madagascar
7
Ethiopia
6
Togo
6
Kenya
6
Eastern Europe
6
Uganda
5
Philippines
5
South Sudan
5
Malawi
5
Mozambique
5
Myanmar / Burma
5
East and Southern Africa
5
Ghana
4
Haiti
4
Iraq
4
Russia
4
Cameroon
3
Niger
3
Zimbabwe
3
Chad
3
Bangladesh
3
Guatemala
3
Middle East and North Africa
3
Sierra Leone
2
Liberia
2
Mali
2
Morocco
2
Syria
2
China
2
Peru
2
Bolivia
2
Chile
2
Eastern Europe and Central Asia
2
Asia
2
Venezuela
2
France
2
Spain
2
Guinea
1
Côte d’Ivoire / Ivory Coast
1
Saudi Arabia
1
Somalia
1
Nepal
1
Jordan
1
Afghanistan
1
Lebanon
1
Zambia
1
Turkey
1
Egypt
1
Tanzania
1
Cambodia
1
Indonesia
1
Mauritania
1
Sudan
1
Argentina
1
Dominican Republic
1
Namibia
1
Cuba
1
Burundi
1
Colombia
1
Honduras
1
Ecuador
1
El Salvador
1
Libya
1
Mexico
1
Nicaragua
1
Yemen
1
South–East Asia Region
1
Western Pacific Region
1
Southern Africa
1
Congo-Brazzaville
1
Tajikistan
1
Qatar
1
Moldova
1
Iran
1
Uzbekistan
1
Kazakhstan
1
Vietnam
1
Tunisia
1
United Kingdom
1
Portugal
1
Belarus
1
Israel
1
Authors & Publishers
Publication Years
Category
Countries
237
Clinical Guidelines
41
Public Health
22
Key Resources
16
Women & Child Health
12
Pharmacy & Technologies
12
Capacity Building
5
Annual Report MEDBOX
1
Toolboxes
COVID-19
206
Mental Health
40
HIV
23
Rapid Response
19
NTDs
15
Planetary Health
14
NCDs
12
TB
11
Global Health Education
11
AMR
10
Caregiver
10
Ebola
9
Cholera
8
Health Financing Toolbox
8
Disability
7
Natural Hazards
6
Pharmacy
6
Conflict
5
Refugee
5
Polio
3
Social Ethics
3
South Sudan
1
Zika
1
Specific Hazards
1
21 January 2022
The overall threat posed by Omicron largely depends on four key questions: (i) how transmissible the variant is; (ii) how well vaccines and prior infection protect against infection, transmission, clinical disease and death; (iii) h
...
Census Report Volume 4-F (Thematic report on Population Projections for the Union of Myanmar, States/Regions, Rural and Urban Areas, 2014-2050)
Key findings
- The total population of Myanmar is estimated to be 65 million by 2050. The projection is based on steadily declining population grow ...
Key findings
- The total population of Myanmar is estimated to be 65 million by 2050. The projection is based on steadily declining population grow ...
Declarations of interests were collected from all external contributors and assessed for any conflicts of interest. Summaries of the reported interests can be found on the SAGE meeting website and SAGE Covid-19 Working Group webpage. This guidance should be considered along with the broader COVID-
...
Cystic fibrosis (CF) was earlier thought to be a disease prevalent in the West among Caucasians. However, quite a number of recent studies have uncovered CF cases outside of this region, and reported hundreds of unique and novel variant forms of CF
...
This document aims to describe a minimum set of surveillance activities recommended at the national level to detect and monitor the relative prevalence of SARS-CoV-2 variants and outline a set of activities for the characterization and assessment of risk posed by these variants. A set of indicators
...
Orientations provisoires
9 août 2021
Le présent document vise à décrire un ensemble minimal d'activités de surveillance recommandées au niveau national pour détecter et surveiller la prévalence relative des variantes du SRAS-CoV-2 et à présenter un ensemble d'activités pour la caractér
...
This document aims to provide interim guidance for microbiology and virology experts, other laboratory professionals, laboratory managers, infectious disease programme managers, public health professionals and other stakeholders that provide primary, confirmatory or advanced testing for SARS-CoV-2,
...
What do we know about the Delta variant so far? How can we assess our risk? What strategies should we apply to protect ourselves whether we are in a low vaccination or high vaccination setting? WHO’s Dr Maria Van Kerkhove explains in Science in 5.
...
Do the current batch of approved vaccines protect us from the Delta variant? What is the level of protection? If you can still get infected even after being fully vaccinated, then why should we vaccinate? WHO’s Chief Scientist Dr Soumya Swaminatha
...
By 2100, new UN figures show that 4 of today’s 10 most populous nations will be replaced by African countries.
Brazil, Bangladesh, Russia and Mexico—where populations are projected to stagnate or decline—will drop out. In their place: Democratic Republic of the Congo, Ethiopia, Tanzania and E
...
Update on SARS-CoV-2 variant of concern Omicron
recommended
Update 70, 10 Dec. 2021
WHO’s Science in 5 Episode #63 - Omicron variant
recommended
What do we know about Omicron variant so far? WHO's Dr Maria Van Kerkhove updates on the transmissibility, severity, symptoms and ways to protect yourself in Science in 5.
Wearing a face mask can help reduce the spread of COVID-19 in the community by reducing the release of respiratory droplets from asymptomatic / pre-symptomatic individuals or those with mild non-specific symptoms. The use of face masks for this purpose may be adopted to reduce the societal impact as
...
Contact tracing and quarantine in the context of COVID-19: interim guidance, 6 July 2022
recommended
Contact tracing for COVID-19 is the process of identifying, assessing, and managing people who have been exposed to someone who has been infected with the SARS-CoV-2 virus, while quarantine is the separation of contacts from other people after exposure to a probable or confirmed case of SARS-CoV-2 i
...
n light of the potential risk posed by SARS-CoV-2 variants, in January 2021 WHO organized an ad hoc consultation to discuss the development of an R&D agenda in response to existing and emerging SARS-CoV-2 variants.
The key objectives were to identify the critical research questions related to var
...
In April 2020, Gavi and COVAX joined the Access to COVID-19 Tools Accelerator (ACT-A) to provide equitable global access to COVID-19 vaccines to tackle the pandemic. In June 2020, the Gavi COVAX Advance Market Commitment (AMC) was launched to finance equitable access in 92 lower-income countries. Si
...
This document aims to describe a minimum set of surveillance activities recommended at the national level to detect and monitor the relative prevalence of SARS-CoV-2 variants and outline a set of activities for the characterization and assessment of risk posed by these variants. A set of indicators
...
